Trial Outcomes & Findings for The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups (NCT NCT03700736)
NCT ID: NCT03700736
Last Updated: 2021-11-23
Results Overview
Recruitment rates will be calculated from the number of patients approached, screened, consented, and randomized.
COMPLETED
NA
62 participants
Baseline
2021-11-23
Participant Flow
Participant milestones
| Measure |
Facebook
6-month post-partum weight loss intervention delivered via a private Facebook group
|
Traditional
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Overall Study
STARTED
|
30
|
32
|
|
Overall Study
COMPLETED
|
27
|
25
|
|
Overall Study
NOT COMPLETED
|
3
|
7
|
Reasons for withdrawal
| Measure |
Facebook
6-month post-partum weight loss intervention delivered via a private Facebook group
|
Traditional
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Overall Study
Pregnancy
|
1
|
1
|
|
Overall Study
Withdrawal by Subject
|
2
|
6
|
Baseline Characteristics
The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups
Baseline characteristics by cohort
| Measure |
Facebook
n=30 Participants
6-month post-partum weight loss intervention delivered via a private Facebook group
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
Total
n=62 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
33.3 years
STANDARD_DEVIATION 3.5 • n=5 Participants
|
32.3 years
STANDARD_DEVIATION 4.4 • n=7 Participants
|
32.8 years
STANDARD_DEVIATION 4.0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
30 Participants
n=5 Participants
|
32 Participants
n=7 Participants
|
62 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
25 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
26 Participants
n=5 Participants
|
26 Participants
n=7 Participants
|
52 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
30 participants
n=5 Participants
|
32 participants
n=7 Participants
|
62 participants
n=5 Participants
|
|
Weight
|
188.9 pounds
n=5 Participants
|
180.6 pounds
n=7 Participants
|
186.0 pounds
n=5 Participants
|
PRIMARY outcome
Timeframe: BaselineRecruitment rates will be calculated from the number of patients approached, screened, consented, and randomized.
Outcome measures
| Measure |
Individuals Contacted
n=606 Participants
Individuals who expressed interest in study participation
|
Traditional
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Recruitment
Could not reach to screen
|
163 Participants
|
—
|
|
Recruitment
Not interested in participating
|
105 Participants
|
—
|
|
Recruitment
Ineligible at initial eligibility screening
|
195 Participants
|
—
|
|
Recruitment
Eligible but did not complete baseline visit
|
65 Participants
|
—
|
|
Recruitment
Eligible at screening but met additional exclusion criteria or did not complete baseline procedures
|
16 Participants
|
—
|
|
Recruitment
Randomized
|
62 Participants
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Latest treatment module participated in based on last intervention meeting attended (Traditional) or last treatment module engaged in based on original posts, replies/comments, reactions, and poll votes (Facebook)
We will calculate sustained participation as time to last intervention session attended in the in-person condition and as time to last post, comment, or reaction (based on date of last post or comment reacted to) in the Facebook condition.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Sustained Participation
|
20 latest treatment module participated in
Interval 19.0 to 20.0
|
18 latest treatment module participated in
Interval 2.0 to 20.0
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Participants reported use of other weight loss programs and seeking weight loss info/support on social media on the 6-month survey. We report the number and percentage of participants in each condition that reported use of other weight loss programs, sought weight loss info/support on social media, both, or neither. These data are available only for participants who completed the 6-month survey. Note that we encouraged participants in both groups to reference online resources (e.g., recipes).
Participants in both treatment conditions will report if they have participated in other weight loss programs (online or in-person), and whether they have searched for weight loss support on Facebook or other online social networks.
Outcome measures
| Measure |
Individuals Contacted
n=26 Participants
Individuals who expressed interest in study participation
|
Traditional
n=28 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Contamination
Used other weight loss programs & sought weight loss info/support on social media
|
1 Participants
|
1 Participants
|
|
Contamination
Used other weight loss programs
|
3 Participants
|
0 Participants
|
|
Contamination
Sought weight loss info or support on social media
|
8 Participants
|
15 Participants
|
|
Contamination
Neither
|
14 Participants
|
12 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Retention is defined as completing 6-month follow-up study assessment (providing weight and/or completing the follow-up survey)
Retention is calculated as the percentage of participants who complete the 6-month follow-up study assessment in each condition.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Retention
Retained
|
27 Participants
|
30 Participants
|
|
Retention
Lost to follow-up
|
3 Participants
|
2 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: Retention is defined as completing 12-month follow-up study assessment (providing weight and/or completing the follow-up survey)
Retention is calculated as the percentage of participants who complete the 12-month follow-up study assessment in each condition.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Retention
Retained
|
28 Participants
|
30 Participants
|
|
Retention
Lost to follow-up
|
2 Participants
|
2 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: Missing (or incomplete) measures needed for cost-effectiveness aim of subsequent efficacy trial: weight and/or quality of life measure.
Percent of participants missing data on each measure/item included in data collection at baseline.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Degree of Missingness in Study Measures
Missing (or incomplete) quality of life
|
4 Participants
|
2 Participants
|
|
Degree of Missingness in Study Measures
Available information on both weight and quality of life
|
26 Participants
|
30 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Missing (or incomplete) measures needed for cost-effectiveness aim of subsequent efficacy trial: weight and/or quality of life measure. Note that as quality of measure was assessed as part of 6-month survey, participants who did not complete the survey are missing this measure.
Percent of participants missing data on each measure/item included in data collection at 6 months.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Degree of Missingness in Study Measures
Missing weight and quality of life
|
3 Participants
|
2 Participants
|
|
Degree of Missingness in Study Measures
Missing quality of life
|
1 Participants
|
3 Participants
|
|
Degree of Missingness in Study Measures
Available information on both weight and quality of life
|
26 Participants
|
27 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: Missing (or incomplete) measures needed for cost-effectiveness aim of subsequent efficacy trial: weight and/or quality of life measure. Note that as quality of measure was assessed as part of 12-month survey, participants who did not complete the survey are missing this measure.
Percent of participants missing data on each measure/item included in data collection at 12 months.
Outcome measures
| Measure |
Individuals Contacted
n=30 Participants
Individuals who expressed interest in study participation
|
Traditional
n=32 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Degree of Missingness in Study Measures
Missing weight and quality of life
|
2 Participants
|
2 Participants
|
|
Degree of Missingness in Study Measures
Missing quality of life
|
0 Participants
|
1 Participants
|
|
Degree of Missingness in Study Measures
Available information for both weight and quality of life
|
28 Participants
|
29 Participants
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Percent weight change from baseline to 6 months. All baseline weights were measured at a study visit. At 6 months, weight was measured at a study visit or participants self-reported current or pre-pregnancy weight (if pregnant). Note that due to COVID19, all follow-up weights for wave 2 were self-reported. Complete case weight change is reported.
Weight will be measured at baseline and 6 months. Percent weight change will be calculated.
Outcome measures
| Measure |
Individuals Contacted
n=27 Participants
Individuals who expressed interest in study participation
|
Traditional
n=30 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Weight Change (Exploratory)
|
-3.0 percent weight loss from baseline
Standard Deviation 7.2
|
-5.4 percent weight loss from baseline
Standard Deviation 6.8
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: Percent weight change from baseline to 12 months. All baseline weights were measured at study visit. At 12 months, weight was measured at study visit or participants self-reported current or pre-pregnancy weight (if pregnant). Note that due to COVID19, all follow-up weights for wave 2 were self-reported. Complete case weight change is reported.
Weight will be measured at baseline and 12 months. Percent weight change will be calculated.
Outcome measures
| Measure |
Individuals Contacted
n=28 Participants
Individuals who expressed interest in study participation
|
Traditional
n=30 Participants
6-month post-partum weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
Weight Change (Exploratory)
|
-2.8 percent weight loss from baseline
Standard Deviation 7.4
|
-4.8 percent weight loss from baseline
Standard Deviation 7.6
|
Adverse Events
Traditional
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Facebook
n=30 participants at risk
6-month behavioral weight loss intervention delivered via a private Facebook group
|
Traditional
n=32 participants at risk
6-month behavioral weight loss intervention delivered via in-person group meetings
|
|---|---|---|
|
General disorders
Communicable disease (e.g., cold, flu)
|
50.0%
15/30 • Number of events 17 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
46.9%
15/32 • Number of events 17 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
|
General disorders
5% or greater weight gain
|
6.7%
2/30 • Number of events 2 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
9.4%
3/32 • Number of events 3 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
|
Injury, poisoning and procedural complications
Musculoskeletal pain or injury (not related to exercise)
|
16.7%
5/30 • Number of events 5 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
12.5%
4/32 • Number of events 5 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
|
Pregnancy, puerperium and perinatal conditions
Pregnancy during intervention or follow-up
|
6.7%
2/30 • Number of events 2 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
9.4%
3/32 • Number of events 3 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
|
Psychiatric disorders
Depressive symptoms
|
40.0%
12/30 • Number of events 13 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
15.6%
5/32 • Number of events 6 • Adverse events were collected during the intervention and at 6-month and 12-month follow-up assessments
Adverse events were spontaneous reported by participants during the intervention and at follow-up assessments. Depressive symptoms and pregnancy were queried at the 6-month and 12-month assessments.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place